Chinese Traditional and Herbal Drugs
|
2025, 56(23): 8634-8644
Shenqi Fuzheng Injection improves cisplatin resistance in A549 cells via PTGS2-BMPER axis
Full
YU Ning1, WANG Ying1, WANG Chun1, WANG Xiaokai2, BO Wei2
Affiliations
1 Liaoning University of Traditional Chinese Medicine, Shenyang 110847, China;
2 Shenyang Medical College, Shenyang 110847, China
doi: 10.7501/j.issn.0253-2670.2025.23.015
Outline
Objective To investigate the mechanism by which Shenqi Fuzheng Injection (参芪扶正注射液, SFI) improves cisplatin (DDP) resistance in A549 cells through prostaglandin-endoperoxide synthase 2 (PTGS2)-BMP binding endothelial regulator (BMPER) axis. Methods A549/DDP cells were intervened with DDP and/or SFI. Network pharmacology was used to predict the targets of SFI in treating lung adenocarcinoma, and its downstream targets were predicted via GEPIA2 website. Control group, DDP group, SFI group, DDP + SFI group and transfection plasmid group were set up. The CCK-8 assay was used to determine the SFI concentration, Edu assay was used to detect proliferation of A549/DDP cells, Transwell assay was detected invasion of A549/DDP cells, flow cytometry was used to detect the apoptosis rate of A549/DDP cells, Western blotting and qRT-PCR were used to detect the protein and mRNA expression levels of PTGS2 and BMPER. A nude mouse transplant tumor model was established, and intervened with DDP and SFI, the expressions of PTGS2 and BMPER in tumor tissue were detected by immunohistochemistry. Results Compared with control group, DDP or SFI intervention groups reduced cell proliferation and invasion (P < 0.01) and elevated apoptosis rate (P < 0.01); Compared with DDP group, DDP + SFI combined treatment further decreased proliferation and invasion (P < 0.01) and markedly increased apoptosis (P < 0.01). Network pharmacology identified PTGS2 as a target of SFI in lung adenocarcinoma, and compared with control group, PTGS2 expressions in A549/DDP cells were significantly decreased after DDP or SFI alone and DDP + SFI combined treatment (P < 0.05, 0.01). Compared with DDP + SFI + Vector group, PTGS2 overexpression markedly promoted proliferation and invasion of A549/DDP cells (P < 0.05) and inhibited cell apoptosis (P < 0.05), whereas PTGS2 knockdown suppressed cell growth (P < 0.01). Compared with PTGS2-KD + Vector group, BMPER overexpression enhanced A549/DDP cells growth (P < 0.05, 0.01) and induced drug resistance, while BMPER knockdown produced the opposite effects (P < 0.05, 0.01). The in vivo experimental results showed that compared with model group, DDP treatment or DDP combined with SFI treatment significantly inhibited tumor growth (P < 0.05, 0.01). Compared with DDP alone treatment, DDP combined with SFI treatment significantly inhibited the growth of transplanted tumors (P < 0.05, 0.01). Conclusion SFI inhibits DDP resistance in A549/DDP cells via PTGS2-BMPER axis.
Shenqi Fuzheng Injection
/
lung adenocarcinoma
/
cisplatin resistance
/
prostaglandin-endoperoxide synthase 2
/
BMP binding endothelial regulator
于宁, 王莹, 王淳, 王晓开, 薄威.
参芪扶正注射液通过PTGS2-BMPER轴改善A549细胞顺铂耐药.
中草药,
2025
, 56
(23)
: 8634
-8644
.
DOI: 10.7501/j.issn.0253-2670.2025.23.015
YU Ning, WANG Ying, WANG Chun, WANG Xiaokai, BO Wei.
Shenqi Fuzheng Injection improves cisplatin resistance in A549 cells via PTGS2-BMPER axis[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(23)
: 8634
-8644
.
DOI: 10.7501/j.issn.0253-2670.2025.23.015
Year 2025 volume 56 Issue 23
53
0
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.23.015
- Receive Date:2025-07-07
- Online Date:2026-11-13